Condensed Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Sales, net	$ 15,172	$ 11,406
Cost of sales	12,799	10,007
Gross profit	2,373	1,399
Selling and administrative expenses	864	923
Operating income	1,509	476
Other income (expense), net:
Interest expense	(76)	(124)
Realized gain on sale of investment in iBio Stock	56
Unrealized loss on investment in iBio Stock	(29)	(20)
Other income, net	8	17
Total other expense, net	(41)	(127)
Income before income taxes	1,468	349
Income tax expense, net	427	37
Net income	$ 1,041	$ 312
Basic net income per common share (in dollars per share)	$ 0.04	$ 0.01
Diluted net income per common share (in dollars per share)	$ 0.03	$ 0.01
Weighted average common shares outstanding - basic (in shares)	29,645,943	29,565,943
Add: Equivalent shares outstanding - Stock Options (in shares)	2,147,133	1,158,690
Weighted average common shares outstanding - diluted (in shares)	31,793,076	30,724,633